Skip to main content

AHK-Cu vs Ipamorelin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

AHK-Cu

AHK-Cu (Copper Tripeptide-3, Alanine-Histidine-Lysine Copper) is a copper peptide similar to GHK-Cu but with different properties. It's used for hair growth and skin rejuvenation applications.

Full details →

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that stimulates the release of growth hormone from the pituitary gland without significantly affecting cortisol or prolactin.

Full details →

Side-by-Side Comparison

AspectAHK-CuIpamorelin
MechanismThe copper-binding tripeptide stimulates collagen synthesis and may promote hair follicle enlargement. Works similarly to GHK-Cu but may have distinct receptor interactions.Acts as a ghrelin mimetic, binding to the ghrelin receptor (GHS-R) in the pituitary to stimulate GH release. Highly selective with minimal effect on other hormones.
Typical DosageTopical: 0.5-2% concentration in serums for skin or scalp applications. Often combined with other growth factors for hair formulations.Typical dosing ranges from 200-300mcg administered 2-3 times daily, often combined with CJC-1295.
AdministrationTopical application to skin or scalp. Can be used with microneedling for enhanced penetration. May cause temporary blue-green tint at high concentrations.Subcutaneous injection. Best results when administered fasted or before sleep. Often stacked with GHRH peptides.
Side EffectsGenerally well-tolerated. May cause skin irritation in sensitive individuals. Temporary discoloration possible.Generally well-tolerated. May cause mild headaches, lightheadedness, or increased hunger initially.
Best For

Key Differences

Detailed Analysis

AHK-Cu and Ipamorelin are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose AHK-Cu for Skin Health & Aesthetics. Choose Ipamorelin for Muscle Growth, Fat Loss, Recovery & Healing, Sleep Quality.

Ready to Learn More?